Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to complete so could be grounds for compensation. Our lawyers are functioning difficult to acquire those hurt by the drug the compensation they are entitled to.













image class="left" url="https://images57.fotki.com/v496/photos/2/3651632/13703394/torivaroxabansideeffects160615-vi.jpg"Even though bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is a lot more harmful than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, individuals may be at danger for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.













In the event you or perhaps a loved a single suffered a significant bleeding event soon after taking Xarelto, you may have legal recourse. For a lot more info, speak to us today to have xareltonewstoday.s3.amazonaws.com your case reviewed, cost-free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Additionally, they are looking for punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.













Visit this page for a lot more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki